Japan's regenerative medicine advisory subcommittee to meet behind closed doors on November 9
Japan's Pharmaceutical Affairs Council will hold a meeting of its Regenerative Medicine Products and Biologically Derived Technologies Subcommittee on Monday, 9 November 2026, from 17:00 to 19:00 at Ministry of Health, Labour and Welfare conference rooms. The session will not be open to the public because it will involve company intellectual property, and disclosing it could give some parties an unfair advantage or disadvantage.
This summary was generated by AI; the official source prevails.
What does it mean?
Japanese health officials are holding a private expert meeting on new regenerative medicine products, such as cell and tissue treatments. The public cannot attend because the discussions involve company trade secrets.
Who is affected?
Companies developing regenerative medicine products and biologically derived technologies seeking approval in Japan.